Improved understanding of the natural biologic processes of wound healing in diabetic patients has begun to change the paradigm of patient care. One of the major goals has been to better characterize the diabetic status with the intent of enhancing dental implant success, controlling periodontal and peri-implant disease, and improving regeneration of bone and periodontal ligament. The successful developments of novel drug delivery systems and diagnostics have assisted the dental practitioner in enhancing predictability of periodontal and implant therapy.
Joseph P. Fiorellini, DMD, DMSc, is program director of the Department of Periodontology at the University of Pennsylvania School of Dental Medicine. He serves on the editorial boards of the Journal of Periodontology and the International Journal of Periodontics and Restorative Dentistry and was the 1994 recipient of the American Academy of Periodontology’s Young Investigator Award. Dr Fiorellini’s areas of research include wound healing around endosseous implant materials, systemic illness, treatment of failing implants, and periodontal diagnostics.
Platform: PC and Mac DVD-ROM